When it comes to CLL/SLL treatment, what’s the difference between BTK inhibitors and BCL-2 inhibitors? Understanding how these treatment approaches work and how they fit into the treatment…
BTK degrader BGB-16673 reduced tumor burden in 85% of patients from a high-risk, hard-to-treat group with relapsed / refractory CLL. Dr. Stephan Stilgenbauer from Ulm University and colleagues…
NEW YORK (Reuters Health) – Disease-free survival with breast cancer is not improved by adding tamoxifen therapy either before or after treatment with letrozole, according to a report…
Miguel Materin, MD, Assistant Professor of Ophthalmology, Director of Ocular Oncology Section Yale University School of Medicine, describes uveal melanoma, a rare cancer but the most common cause…
NEW YORK (Reuters Health) – The tyrosine kinase inhibitor gefitinib is more effective than standard therapy with carboplatin-paclitaxel for lung adenocarcinomas with mutations in the epidermal growth factor…
NEW YORK (Reuters Health) – Roughly 56% of melanomas detected in general dermatology practice are found through full-body skin examinations (FBSE), not as the result of patient complaint,…
NEW YORK (Reuters Health) – Use of 18F-FDG PET imaging can reduce the rate of futile laparotomies in patients with colorectal liver metastases from 45% to 28%, according…
NEW YORK (Reuters Health) – A meta-analysis of trial data suggests that erythropoietin can be safely used to treat anemia in patients with chronic heart failure and may…
Michael Benninger, MD, Chairman, Head and Neck Institute, Cleveland Clinic, discusses myths surrounding sinus disease. Headaches are not caused by sinus infection, and postnasal drip is often mistaken…
Michael Benninger, MD, Chairman, Head and Neck Institute, Cleveland Clinic, discusses Wegener’s granulomatosis, the subglottic stenosis that often accompanies this disease, and the treatment challenges. Summary: 1. Wegener’s…
Michael Benninger, MD, Chairman, Head and Neck Institute, Cleveland Clinic, discusses the effects of herd immunization with pneumococcal vaccination. Summary: Community vaccination against pneumococcal disease has showed a…
NEW YORK (Reuters Health) – Even with its toxic effects, adjuvant chemotherapy improves quality-adjusted survival in patients with non-small-cell-lung cancer, according to a report in the Journal of…
